The heterochromatin protein 1 (HP1) family is involved in various functions with maintenance of chromatin structure. During murine somatic cell reprogramming, we find that early depletion of HP1g reduces the generation of induced pluripotent stem cells, while late depletion enhances the process, with a concomitant change from a centromeric to nucleoplasmic localization and elongation-associated histone H3.3 enrichment. Depletion of heterochromatin anchoring protein SENP7 increased reprogramming efficiency to a similar extent as HP1g, indicating the importance of HP1g release from chromatin for pluripotency acquisition. HP1g interacted with OCT4 and DPPA4 in HP1a and HP1b knockouts and in H3K9 methylation depleted H3K9M embryonic stem cell (ESC) lines. HP1a and HP1g complexes in ESCs differed in association with histones, the histone chaperone CAF1 complex, and specific components of chromatin-modifying complexes such as DPY30, implying distinct functional contributions. Taken together, our results reveal the complex contribution of the HP1 proteins to pluripotency.
INTRODUCTION
Embryonic stem cells (ESCs) have the unique ability to selfrenew indefinitely and differentiate into several cell types in response to the appropriate stimuli. This remarkable plasticity is correlated with a chromatin structure that is less enriched for compacted heterochromatic DNA and has a higher mobility of chromatin-associated proteins such as heterochromatin protein 1 (HP1) alpha than somatic cells (Fussner et al., 2011; Shchuka et al., 2015) .
In mammals, the HP1 family consists of three proteins: HP1a, HP1b, and HP1g, which have a highly conserved chromodomain that binds to histone H3 lysine 9 methylation (H3K9me), a transcriptionally repressive chromatin modification, and a chromoshadow domain that is involved in protein-protein interactions (Bannister et al., 2001; Smothers and Henikoff, 2001) . While the HP1 proteins participate in diverse cellular processes in somatic cells, such as nucleating regions of repression (Nielsen et al., 1999) , their role in pluripotency is poorly understood. The depletion of the HP1 proteins in mouse ESCs does not lead to an extensive change in mRNA or repetitive element expression (Bulut-Karslioglu et al., 2014; Maksakova et al., 2013; Mattout et al., 2015; Sridharan et al., 2013) , but may affect splicing in conjunction with DNA methylation (Smallwood et al., 2012; Yearim et al., 2015) . In mouse ESCs, knockout of HP1b impaired pluripotency and mesodermal differentiation (Mattout et al., 2015) , while HP1g depletion leads to endodermal and neural differentiation defects (Caillier et al., 2010; Huang et al., 2017) . The HP1b knockout mouse is perinatally lethal due to neural defects, whereas the HP1g knockouts, although viable, exhibit severe infertility (Aucott et al., 2008; Brown et al., 2010; Takada et al., 2011) .
Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) that resemble ESCs (Takahashi and Yamanaka, 2006) provides an opportunity to examine how each of these proteins can influence the acquisition of pluripotency. We have previously found that depleting HP1g caused a greater increase in murine reprogramming efficiency than depleting HP1a or HP1b (Sridharan et al., 2013) . To investigate differing functional roles for these proteins, we performed immunofluorescence assays and found that, unlike HP1a, the majority of HP1g was nucleoplasmic upon reaching the iPSC state. Concomitant with this change in localization, there was an increase in iPSCs obtained with a knockdown of HP1g. Proteomics characterization of HP1g complexes from mouse ESCs and reprogramming intermediates called partially reprogrammed cells (pre-iPSCs) revealed enrichment with elongation-associated histone H3.3 and linker histone H1 respectively. The depletion of SUMO protease Senp7, which anchors HP1 to heterochromatin (Maison et al., 2011 (Maison et al., , 2012 Romeo et al., 2015) and is more enriched with HP1g in pre-iPSCs, increases reprogramming efficiency. In ESCs, we identified interactions of HP1g with pluripotency-related proteins DPPA4 and OCT4. Although all three HP1 proteins
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(legend on next page) interacted with chromatin-associated complexes, HP1g was more enriched for certain components, such as DPY30 of the MLL complex, suggesting that subunit composition may aid in targeting different HP1 proteins. We found several post-translational modifications of the HP1 proteins in ESCs. These results provide insights into how the interactions of these important heterochromatin proteins influence their role in pluripotency.
RESULTS

HP1g Localization Changes with Temporal Requirement in Reprogramming
In order to determine how the localization of HP1g changed during the generation of iPSCs, we initiated reprogramming in mouse embryonic fibroblasts (MEFs). Similar to HP1a, HP1g colocalized with punctate DAPIintense heterochromatin in greater than 80% of MEFs (Figures 1A , 1B, 1C, and S1A). In ESCs, HP1g was almost completely nucleoplasmic (91.9%), in contrast with colocalization of HP1a with the DAPI foci (70.1%) (Figures 1A and S1B). The transcript levels of HP1g plateaued at day 6 of reprogramming, similar to those of HP1a and HP1b (Figure S1B ). By day 6, the reprogramming cells had clustered to form colonies that did not express pluripotency factor Nanog, but HP1g was already in a more nucleoplasmic configuration. This suggests that HP1g relocalization precedes iPSC formation. By day 8 of reprogramming, $70% of the Nanog-positive iPSC colonies had a mostly nucleoplasmic distribution of HP1g ( Figures 1A, 1B , and S1C).
In contrast, $60% of iPSC colonies had punctate localization for HP1a ( Figures 1A, 1C , and S1C). To observe whether HP1g that was nucleoplasmic returned to a punctate localization, we performed time-lapse live-cell imaging. Exogenously expressed GFP-tagged HP1g in MEFs showed a punctate localization, similar to endogenous HP1g ( Figure S1D ). Upon reprogramming, the GFP-tagged HP1g changed in localization from a punctate to nucleoplasmic location. Importantly, nucleoplasmic HP1g retained such localization during reprogramming ( Figure S1D and Movie S1).
To determine whether this temporal change in localization had any functional effects, we performed a time course of HP1g depletion by using small interfering RNA (siRNA)-mediated knockdown ( Figure S2A ) during reprogramming ( Figures 1D and S1C ). Remarkably, when HP1g was depleted early in reprogramming (day À1), efficiency was reduced compared with depletion later (day 6) when efficiency was increased ( Figure 1D ). The early reduction in colony number was not due to reduced cell numbers during reprogramming of HP1g-depleted MEFs ( Figure S2B ). Since the reprogramming population represents a heterogeneous mixture of cells that could respond to HP1g depletion differently, we used a pre-iPSCs system. Pre-iPSCs are clonal transcriptional intermediates of the reprogramming process that have not activated the pluripotency network and can convert to iPSCs at low efficiency with HP1g depletion (Sridharan et al., 2013 (Sridharan et al., , 2009 . HP1g is largely nucleoplasmic in pre-iPSC ( Figure 1E ). We have recently developed a method where the combination of ascorbic acid and 2i (mitogen-activated protein kinase [MAPK] and Figure 1 . Differential Localization and Function of HP1g during Reprogramming (A) Immunofluorescence for HP1g (top panel) and HP1a (bottom panel) in (i) mouse embryonic fibroblasts (MEFs), (ii) at different time points in reprogramming populations, and (iii) embryonic stem cells (ESCs). Scale bar, 10 mm. Inset: zoomed image of a region (white box). Inset scale bar, 10 mm. (B) (i) Cell counts of punctate, non-punctate, and semi-punctate HP1g localization in reprogramming MEFs, plotted as a fraction of the total cells counted, N. Semi-punctate refers to a generally more nucleoplasmic localization, but still exhibiting <3 punctate spots.
(ii) Colony counts of punctate, non-punctate, and mixed HP1g localization in reprogramming colonies, plotted as a fraction of the total colonies counted, N. (C) (i) Cell counts of punctate, non-punctate, and semi-punctate HP1a localization in reprogramming MEFs plotted as a fraction of the total cells counted, N. Semi-punctate refers to a generally more nucleoplasmic localization, but still exhibiting <3 punctate spots.
(ii) Colony counts of punctate, non-punctate, and mixed HP1a localization in reprogramming colonies, plotted as a fraction of the total colonies counted, N. (legend continued on next page) glycogen synthase kinase [GSK] inhibition) converts preiPSCs to iPSCs at 80% efficiency (Tran et al., 2015) . Given the robustness of this conversion, very few modulators are expected to have a further effect. We depleted HP1g in this high-efficiency system and found that reprogramming kinetics increased, with a significant number of Nanog-GFP reporter-positive cells appearing by day 4 (Figures 1E and S2A ). Thus, after the change in localization of HP1g from DAPI associated to more nucleoplasmic, depleting the levels of HP1g increases reprogramming efficiency.
High Salt and Nuclease Digestion Release Different Kinds of HP1g Complexes
To investigate these changing requirements for HP1g, we decided to identify interactors of HP1g that correlate with the cell fate change to a pluripotent state. In general, transcription factors are soluble by extraction with 0.42 M salt (Dignam et al., 1983) . We extracted nuclear proteins from ESCs at increasing salt concentrations from 0.15 M to 0.42 M and with micrococcal nuclease (MCN) digestion to release nucleoplasmic or chromatin-bound proteins respectively. In parallel with the increasing amount of soluble proteins proportional to the salt concentration in isolated nuclei ( Figure S2C ), immunoblotting for HP1g revealed that 59% remained in the insoluble pellet fraction under 0.42 M salt conditions, while 46% of HP1g remained in the pellet at 0.3 M salt in MCN conditions ( Figure 2A ). Thus, the more nucleoplasmic localization of HP1g in pluripotent cells does not translate to complete extraction even at 0.5 M salt. ESC lines with N-terminal FLAG-epitope-tagged HP1g at a single genomic location were generated and induced to mimic endogenous levels ( Figure S2D ). From these ESC lines, anti-FLAG immunoprecipitation followed by mass spectrometry (IP-MS) was performed in nuclear extracts prepared with different salt and enzymatic conditions (Experimental Procedures, Figures 2B and 2C, Table S1 ). The 0.42 M salt and MCN + 0.15 M salt yielded $66 interacting proteins compared with 381 interactors in the MCN + 0.3 M salt condition ( Figure 2C ). Components of the centromere proximal complex (e.g., INCENP), histone-modifying enzymes that regulate centromere assembly (e.g., KAT7) (Ohzeki et al., 2016) , and several zinc finger proteins (e.g., ZFP600 and ZNF512) were found in both MCN + salt conditions. HP1g interacted with PRMT5, an arginine methyltransferase, and CBX7, a polycomb-related protein, exclusively in 0.42 M salt extraction. In both the high-salt conditions, WDR5, a protein in the MLL complex, was enriched ( Figure 2C ). Thus HP1g-associated protein complexes can be partitioned in biochemically distinct environments.
To determine the pluripotent-specific interactions of HP1g in the MCN + 0.3 M salt condition, we identified proteins whose gene expression level was 10-fold greater in ESCs compared with MEFs (Sridharan et al., 2009) . We found the ESC-specific protein REX2, an uncharacterized zinc-finger-domain-containing protein, two poorly studied ESC-specific proteins, DPPA2 and DPPA4, and L1TD1, a protein involved in RNA post-transcriptional processes as HP1g interactors (Figures 2B and 2C and Table S1 ). ESC-enriched transcription factors including UTF1, OCT4, and ESRRB, but not NANOG, were also detected in this pulldown ( Figure 2B ). We also found interactions with the MIS12-containing DNA replication complex, the chromatin remodeling NuRD complex, and FACT complexes ( Figure 2D ). We next applied these extraction conditions to pre-iPSCs for comparative profiling.
Differential Association of HP1g Complexes in PreiPSCs
We generated FLAG-tagged HP1g pre-iPSC lines with expression equivalent to endogenous HP1g levels (Figure S3A) and performed IP-MS in MCN + 0.3 M salt conditions. Similar to ESCs, interactions of HP1g with the histone chaperone CAF1 complex and H3K9 methyltransferases were detected in pre-iPSCs (Figures 3A and S3B and  Table S1 ). Certain pluripotency-specific interactions of HP1g, such as with L1TD1 and ZFP57, were already detected at the pre-iPSCs stage, likely because their expression had already reached ESCs levels ( Figures 3A, 3B , and S3B).
We exploited the sensitivity of the mass spectrometry approach to observe subtle changes in composition of chromatin-related complexes that are unlikely to be detected by western blots. Among the PRC2 members, JARID2 and MTF2 are less enriched in pre-iPSCs and the ORC complex is less abundant in its interaction with HP1g ( Figures 3B and 3C ). The GATAD2B (P66b) component of the NuRD complex is more enriched in preiPSCs compared with ESCs ( Figures 3B and 3C ). By gene Significantly enriched proteins, red; bait, blue; significantly enriched proteins that are also expressed >10-fold higher in ESC compared with MEF, bold red. See also Figure S2 and Table S1 .
expression levels all these components are similarly expressed in pre-iPSC and ESCs (Sridharan et al., 2009 ). The FACT complex, which disrupts the H2A-H2B dimer to allow RNA polymerase to read through and promotes transcription elongation, is less enriched in pre-iPSCs than in ESCs ( Figure 3C ).
A striking difference between the two cell types was in the association of HP1g with specific histones. In preiPSCs, there was a significant enrichment of HP1g with the histone H1 proteins that play a role in chromatin compaction ( Figures 3B and 3C ). There was also a lower enrichment of histone H3.3, which is associated with transcription elongation and the DNA-repair-associated H2AX in pre-iPSCs ( Figures 3B and 3C ) (Ahmad and Henikoff, 2002; McKittrick et al., 2004) . To confirm this differential enrichment, we generated V5-tagged H3.3 ESC and Figure 2B ) and pre-iPSC (as in Figure S3B ). Known interactors of HP1, magenta; previously unidentified interactors of HP1, black; interactors of HP1 that are also expressed >5-fold higher in ESC compared to pre-iPSC, bold black. See also Figure S3 and Table S1 .
pre-iPSC cell lines ( Figure 3D ). By performing immunoprecipitation for FLAG-HP1g we were able to quantify the levels of H3.3 that was specifically bound in each cell type. There was a 2.5-fold increase in the amount of H3.3 association in ESCs compared with pre-iPSCs, verifying the results from mass spectrometry ( Figure 3D ). Taken together, the increased HP1g interaction with H3.3 and the FACT complex is likely to promote transcriptional elongation in ESCs.
SENP7 May Aid in Release of HP1g in Pre-iPSCs
HP1a undergoes a SUMOylation-deSUMOylation cycle for recruitment to centromeric regions (Maison et al., 2012 (Maison et al., , 2011 Romeo et al., 2015) . Initially SUMO-1 adds SUMOgroups to HP1a, leading to centromeric recruitment followed by deSUMOylation by SENP7, leading to centromeric anchoring. There was a greater association of SENP7 with HP1g in pre-iPSCs compared with ESCs (Figure 3B) . Quantitative immunoprecipitation revealed a 5-fold greater interaction of SENP7 with HP1g in pre-iPSCs compared with ESCs ( Figure 4A ). To determine whether the differential association of SENP7 with HP1g had a functional consequence for pluripotency, we depleted Senp7 in pre-iPSCs during reprogramming ( Figure S4A ). Using the same high-efficiency system for conversion of pre-iPSCs as in Figure 1 , we found that the decrease in Senp7 caused an increase in reprogramming efficiency and kinetics, similar to what is observed with depletion of HP1g ( Figure 4B ). Interestingly the combined depletion of both Senp7 and HP1g did not enhance the conversion efficiency to the iPSC state ( Figure 4B ). This result suggests that both SENP7 and HP1g act in the same pathway and that reducing the anchoring of HP1g is important for reaching the pluripotent state.
Pluripotency Factor Association of HP1g
We chose to interrogate its interaction with pluripotency factors OCT4 and DPPA4 in further detail. DPPA4 is a SAPdomain-containing protein (Maldonado-Saldivia et al., 2006) . Both HP1g and Dppa4 knockout mice have defects in spermatogenesis (Brown et al., 2010; Madan et al., 2009; Nakamura et al., 2011; Takada et al., 2011) .
We confirmed the interaction of both endogenous and FLAG-tagged HP1g with OCT4 and DPPA4 ( Figures 5A  and S5A ). The reciprocal IP using DPPA4 antibody also confirmed HP1g as a bona fide interactor ( Figure 5B ). These interactions were retained after immune complexes were washed at 0.5 M salt ( Figure S5B ) and were specific because other abundant proteins in ESCs, such as DPPA3, were not immunoprecipitated ( Figure S5A ). These interactions were also retained after Benzonase digestion ( Figure S5C ), indicating that the interaction was not due to spurious DNA bridging. Interestingly, DPPA4 and HP1g colocalize in the nucleoplasm of interphase nuclei but not in mitotically dividing cells, as observed by confocal microscopy (Figure 5C ). DPPA4 remains tightly localized to DAPI-stained DNA, which may suggest a function in mitotic bookmarking that is independent of its association with HP1g or at least the mitotically associated Ser-83 phosphorylated form of HP1g (Leonard et al., 2015) .
Since HP1g forms heterodimers with HP1a and HP1b, we examined whether OCT4 and DPPA4 require heterodimerization to interact with HP1g. Using CRISPR-based technology we generated knockout ESC lines of HP1a or HP1b individually ( Figures 5D and S5D ). The levels of HP1g were not affected in these cell lines and both the knockout cell lines could be propagated efficiently (data not shown). In the context of the HP1a or HP1b knockout (KO), HP1g interaction with both OCT4 and DPPA4 was retained ( Figure 5E ). DPPA4 contains a PxVxL motif that is commonly found in several HP1-interacting proteins (Thiru et al., 2004 ) and could represent the interaction surface. However, mutation of this motif did not affect the binding of DPPA4 to HP1g ( Figure S5E ). Moreover, the interaction between DPPA4 and HP1g was only observed under the MCN extraction conditions, which release chromatin-bound proteins (legend continued on next page) ( Figure 2C ). Therefore, we wondered whether the interaction of DPPA4 with HP1g was due to the embedding of DPPA4 in H3K9 methylation-enriched heterochromatin.
To deplete H3K9 methylation, we generated ESC lines with a stable integration of a histone H3.3 lysine 9 to methionine mutation (H3K9M) (Lewis et al., 2013) . This mutant form of H3.3 has been shown to trap the SETdomain-containing histone methyltransferases (Lewis et al., 2013) . ESC lines with greater than 90% reduction in H3K9me2 and H3K9me3 were obtained ( Figure 5F ) and could be propagated, while H3K9me1 remained unaffected ( Figure S5F ). Despite severe depletion of H3K9me2/ me3, the interaction between HP1g and both OCT4 and DPPA4 was retained ( Figure 5G ), suggesting that the proteins were not interacting exclusively in the context of a H3K9 methyl-containing nucleosome. Thus, from our protein complex isolation, we have identified ESC-specific direct interactors of HP1g in pluripotent cells.
Differential Interactions and Modifications of the HP1 Proteins in Pluripotent Cells
Given the observation that reduction of HP1g levels increases reprogramming efficiency better than HP1b or HP1a (Sridharan et al., 2013 ) and the differential localization of the HP1 proteins in ESCs, we next wanted to determine if they participated in distinct complexes. At the protein level, approximately similar numbers of peptides are recovered from each of the HP1 proteins from mouse ESCs, suggesting similar protein expression levels (Graumann et al., 2008; Van Hoof et al., 2006) . We generated independent ESC lines that were induced for FLAG-HP1a or FLAG-HP1b expression and subjected the nuclear extracts to IP-MS following the same procedure as for HP1g and compared the protein profiles obtained ( Figure 6A and Table S2 ). The HP1a-containing complexes were more enriched for several zinc-finger-containing proteins, including ZNF219, a known transcriptional repressor with roles in osteogenic differentiation (Takigawa et al., 2010) ; the LIM-domain-containing proteins, PDLIM1 and PDLIM4; and the chromatin assembly factor (CAF1) component CHAF1B ( Figure 6A ). In HP1b there was greater enrichment of TCOF ( Figure 6A ), a transcription factor involved in Treacher-Collins syndrome that affects neural crest development (Valdez et al., 2004) , which may explain the neuronal defects in the HP1b knockout mice.
When comparing the bait proteins themselves, HP1a and HP1b were better enriched in their own complexes compared with HP1g, which was present at similar levels in HP1a and HP1b complexes ( Figure 6B ). This may suggest a tendency for HP1a and HP1b to homodimerize and for HP1g to heterodimerize in ESCs. DPY30, which is a core subunit of the MLL-H3K4 methyltransferase complex, was more enriched in the HP1g pull-down ( Figure 6B) . Similarly, RING1, a component of both the E2F6 and PRC1-like complexes, and the components GATAD2B and HDAC2 of the NuRD complex, were more abundant in the HP1g interactions (Figure 6B) . Members of the CAF-1 complex are more enriched with HP1a pull-down ( Figure 6A ). We confirmed the increased association of DPY30 with HP1g and CHAF1B with HP1a by performing FLAG immunoprecipitation followed by western blotting ( Figure 6C ). These data suggest that these specific components could partition the chromatin-modifying complexes between the different HP1 proteins.
Interestingly, there was a striking enrichment for histone H3.3 in the HP1g pull-down, while variants of H2A, such as H2A.Z, remained constant in abundance between the HP1 pull-downs ( Figure 6B ). In contrast, both the HP1a and HP1b were enriched for histone H1. Given the differential association of histone H1 and H3.3, the HP1a interactome in ESCs resembles the HP1g interactome in pre-iPSCs ( Figure 3B ).
We probed these histone associations further by querying the histone post-translational modifications that were detectable. Both HP1g and HP1b were associated with H3K79me2, a transcription elongation mark (Jonkers and Lis, 2015) , and HP1g with H3K23ac, which is associated with active chromatin (Lu et al., 2015) ( Figure S6A and Table S3 ). We confirmed the association of HP1g with H3K79me2 by immunoblotting for this modification after IP with FLAG-HP1g ( Figure 6D ). In addition to known histone modifications on histone H3 and H4 associated with HP1a and HP1b in somatic cells (Leroy et al., 2012) , we found H2BK5 acetylation and H1S1 acetylation, both histone modifications of unknown function ( Figure S6A and Table S3 ). Note that the mass spectrometry analysis was not tailored to detect histone modifications on the N-terminal tail and hence H3K9 methylation was not identified in this analysis.
The HP1 proteins themselves are decorated with multiple post-translational modifications (Leroy et al., 2009; Lomberk et al., 2006a Lomberk et al., , 2006b ) in somatic cells, but the status of these modifications in pluripotent cells is unknown. We found a previously unreported phosphorylation on S97 of the hinge domain of HP1g (Figures 6E and S6B and  Table S3 ) in ESCs. Both S132 and S129 phosphorylations were detected on HP1b and HP1a, but not in HP1g (D) Western blot of co-immunoprecipitation of H3K79me2 with FLAG-HP1g. (E) Post-translational modifications (PTMs) of HP1a, HP1b, and HP1g found in ESC in red. Previously unidentified PTMs are in red with yellow highlights. Chromodomain, chromoshadow domain, and hinge domain are indicated. See also Figure S6 , Table S2, and Table S3 .
( Figure 6E ). These modification positions are part of the chromoshadow domain, suggesting that some of the HP1 protein functions could differ because of the different post-translational modifications ( Figure 6E and Table S3 ).
DISCUSSION
Pluripotent cells have smaller blocks of heterochromatin as imaged by microscopy (Ahmed et al., 2010; Fussner et al., 2011) . The histone H1 and HP1 proteins have lower residence time in chromatin and therefore are much more mobile in pluripotent cells compared with differentiated cells (Melcer and Meshorer, 2010; . In this study, we have found that HP1g, which becomes almost completely nucleoplasmic in mouse ESCs, increases in its association with histone H3.3 but decreases with histone H1 compared with pre-iPSCs. H3.3 is a replication-independent histone that is deposited during transcription elongation. Our earlier results using chromatin immunoprecipitation sequencing (ChIP-seq) in pre-iPSCs and in ESCs have shown that the distribution of HP1g in pre-iPSCs is both at the promoter and in the coding region of the genes, while in ESCs the binding is largely restricted to the gene body (Sridharan et al., 2013) . Taken together these results imply that HP1g becoming more nucleoplasmic may aid in its recruitment to transcriptionally active regions.
The change in reprogramming efficiency with temporal depletion of HP1g suggests that in somatic cells HP1g is required for responsiveness to the reprogramming factors. Later in reprogramming, after HP1g is in a nucleoplasmic configuration, the transient depletion of HP1g may allow release from histone H1 association and lead to the gain of pluripotency.
HP1g interacts with several pluripotency proteins, including OCT4 and ESRRB. One intriguing interaction is with DPPA4, a SAP-domain-containing protein of unknown function that is exclusively expressed in ESCs. Previous studies had suggested a lack of interaction between HP1a and DPPA4 due to the non-overlapping nucleoplasmic distribution and an overlap of DPPA4 with RNA polymerase by immunofluorescence (Masaki et al., 2007) . The association of DPPA4 and HP1g may suggest a different role for DPPA4 in transcription elongation or splicing. While OCT4 is associated with transcription activation and polycomb-mediated repression, from our study it is intriguing that OCT4 also associates with HP1g. A role for OCT4 in splicing has not been reported, suggesting that OCT4 and DPPA4 may interact with HP1g in independent complexes.
The HP1 proteins are expressed in many tissues and participate in several chromatin-altering multi-subunit complexes. The preferential binding of HP1g to some components of these complexes, such as DPY30 of the MLL complex and GATAD2B of the NuRD complex, suggests that the function of the complexes may change depending on the type of HP1 bound. The affinity of recombinant HP1 proteins to H3K9 methylation is affected by post-translation modification of HP1 (Hiragami-Hamada et al., 2011) . It is interesting to note that the posttranslational modifications on HP1a and HP1b were not detected in HP1g, although they occur in the highly conserved chromoshadow domain. These results suggest that post-translational modifications may regulate the ability of HP1 proteins to participate in specific chromatin-modifying complexes in pluripotent cells. Taken together, our results provide evidence for the compartmentalization of the HP1 proteins in both localization and participation in complexes as cells transition in and out of pluripotency (Figure 7) . Although the core pluripotency transcriptional network is conserved between mouse ESCs and human ESCs, they differ in several aspects, including dependence on distinct signaling networks for maintaining pluripotent characteristics. It will be intriguing to determine if the specific interactions and putative functional compartmentalization of the HP1 proteins is conserved in human pluripotent cells.
EXPERIMENTAL PROCEDURES
Derivation and Maintenance of Cell Lines
N-terminal 3X-FLAG-tagged HP1a, HP1b, or HP1g were recombined into the tet-inducible V6.5 ESC line (Beard et al., 2006) . FLAG-tagged protein expression was induced with 1 mg/mL doxycycline. FLAG-HP1g ESC cell lines with V5-tagged H3.3 wild-type In non-pluripotent cells and reprogramming intermediates, HP1g interacts with SENP7, which anchors HP1g to H3K9me2/3 histones in the heterochromatin, depicted as red or yellow circles. HP1g is also more enriched with linker histone H1 in reprogramming intermediates. During reprogramming, the release of HP1g from being anchored to the heterochromatin is required to attain pluripotency. In pluripotent cells, HP1g interacts with histone H3.3 and histone elongation mark H3K79me2. Moreover, OCT4 and DPPA4 are among the interactors of HP1g in pluripotent cells that occur independently of H3K9me3 but may be dependent on other modifications (black circle).
(WT), V5-tagged H3.3 K9M mutant, V5-tagged Dppa4 WT, V5-tagged Dppa4 V81S mutant, or V5-empty were generated by lentiviral transduction. Guide RNAs targeting HP1a (GTTGGA CAGGCGCATGGTTAAGG) or HP1b (CTTGATCGGCGAGTTGT CAAGG) were used to generate knockout ESC lines as described by Mali et al. (2013) . Pre-iPSC line (Sridharan et al., 2013 ) with FLAG-HP1g or FLAG-empty single or with V5-tagged H3.3 were generated by lentiviral transduction. All cell lines were maintained on irradiated MEFs in ESC media (KnockOut DMEM, 15% fetal bovine serum (FBS), L-glutamine, penicillin/streptomycin (pen/ strep), non-essential amino acids, 2-mercaptoethanol, and leukemia inhibitory factor). MEFs were cultured in DMEM, 10% FBS, and penicillin/streptomycin media.
Reprogramming Experiments
Reprogramming was initiated with 2 mg/mL doxycycline in MEFs homozygous for Oct4-Klf4-Sox2-Myc allele and heterozygous for the rtTA allele, as described (Tran et al., 2015) . For live-cell timelapse imaging, reprogrammable MEFs were lentivirally transduced with N-terminally tagged GFP HP1g, and selected with Geneticin for 5 days. Pre-iPSC conversion was induced with ascorbic acid (AA, 50 mg/mL; Sigma) and 2i (1 mM PD-0325901; Stemgent; 3 mM CHIR-99021; Stemgent), and siRNA transfection was performed as in Tran et al. (2015) . All procedures involving animals were approved by the Institutional Animal Care and Use Committee of University of Wisconsin-Madison.
Protein Extraction and Immunoprecipitation
Cell pellets were extracted in buffer A (10 mM HEPES [pH 7.9], 1.5 mM MgCl 2 , 10 mM KCl, 1 mM DTT, phosphatase inhibitor and protease inhibitor cocktail) followed by nuclear pellet extraction in buffer C (0.42 M KCl, 20 mM HEPES [pH 7.9], 0.2 mM EDTA [pH 8.0], 5% glycerol, 1 mM DTT, phosphatase and protease inhibitor cocktail); or in micrococcal nuclease digestion buffer (MCN; 50 mM Tris [pH 7.6], 1 mM CaCl 2 , 0.2% Triton X-100, phosphatase inhibitor and protease inhibitor cocktail) with 20 units of S7 micrococcal nuclease per 1 3 10 5 cells for 10 min at 37 C and stopped with 50 mM EDTA. NaCl to appropriate levels was added and incubated at 4 C for 1 hr before centrifuging at 13,000 g for 30 min to isolate soluble nuclear extracts. Percentage of HP1g in the supernatant (S) or pellet (P) fraction was determined by quantifying the immunoblot band intensity using ImageJ of each fraction over the total (S + P). For FLAG-IP-MS, 20mg of nuclear extract was incubated with 150 mL of FLAG-M2 agarose beads (Sigma, 50% slurry) for 2 hr at 4 C, washed thrice with MCN buffer with 0.3 M NaCl, followed by washing twice with the same buffer but without Triton X-100. IP complexes were eluted with 150 ng/mL 3X FLAG peptide (Sigma) in MCN buffer without Triton X-100. Eluted protein complexes were trichloroacetic acid (TCA) precipitated, in-solution digested with trypsin (Wisniewski et al., 2009) , and injected on an Orbitrap mass spectrometer (LTQ Velos, Thermo Fisher Scientific). Three independent immunoprecipitations for pre-iPSC FLAG-HP1g, and two independent immunoprecipitations for ESC FLAG-HP1g, FLAG-HP1a, and FLAG-HP1b were performed. For immunoblots, 1.5 mg of nuclear extract was immunoprecipitated with 10 mg of specific antibody or immunoglobulin G (IgG) overnight, collected with 100 mL of Protein G magnetic beads (Bio-Rad) and eluted in Laemmli sample buffer. For endogenous IP with Benzonase, nuclear extracts were dialyzed to remove EDTA using a 7000 MCO Dialysis cassette (Thermo Fisher Scientific) overnight at 4 C, and 167 U of Benzonase (Sigma) was added per milliliter of dialyzed extracts, supplemented with MgCl 2 to 1.5 mM and incubated at 4 C for 2 hr before proceeding with immunoprecipitation as above.
Mass Spectrometry Analysis
Thermo RAW files from tandem mass spectrometry (MS/MS) were analyzed using MaxQuant (Cox et al., 2014; Cox and Mann, 2008 ) version 1.5.6.5 and searched against the reviewed Mus musculus Swiss-Prot proteome database using the following parameters: trypsin/P digest enzyme with strict trypsin specificity; fixed mod, carbamidomethylation; variable mod, oxidation of methionine; fragment ion mass tolerances, 20 ppm; precursor mass tolerances, 4.5 ppm; peptide false discovery rate (FDR), 1%; protein FDR, 1%.
To calculate protein intensities across samples, the options ''Match between runs'', and label-free quantification (LFQ) were selected to obtain MaxLFQ. The output file ''proteinGroup.txt'' was further analyzed using Perseus version 1.5.6.0 for downstream statistical analyses of the normalized protein intensities. Protein lists were filtered to remove potential contaminants, hits to the reverse decoy database, and those only identified by modified peptide. We required that each protein be identified in all independent IP-MS samples from each group. Protein LFQ intensities were logarithmized and missing values imputed by values simulating noise around the detection limit. Contaminants from non-nuclear organelles were removed from the final list of proteins by performing DAVID GO analysis (https://david.ncifcrf.gov/). We performed two-sided t tests with permutation-based FDR cutoff of 1% (S0 = 3). Lists of known interactors of HP1 were obtained from BIOGRID, a database of interaction dataset (https://thebiogrid. org/), as well as previous HP1 IP-MS studies in various cell types (Nozawa et al., 2010; Rosnoblet et al., 2011; Vermeulen et al., 2010) . Members of complexes were retrieved from NCBI (https://www. ncbi.nlm.nih.gov/gene) and GeneCards (www.genecards.org).
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